Evaluation of Adverse Drug Reaction Reporting Among Traditional Medicine Practitioners in Zaria Kaduna State Nigeria doi.org/10.26538/tjnpr/v3i3.4
Main Article Content
Abstract
The wide use of traditional medicines has remained a serious concern particularly when it comes to safety. This study was aimed at assessing the knowledge, perception and barriers for Adverse Drug Reaction (ADR) reporting among traditional medicine practitioners (TMPs). This study was a cross sectional study among TMPs in Zaria Nigeria using a structured questionnaire. A response rate of 87.5% (105) was recorded. The TMPs were mostly males 86 (81.9%) with a mean age of 40.8 ± 12.9 years. Majority of the TMPs have never come across ADR 64 (61.0%) didn’t know how to report ADR 62 (59.0), with no training on ADR reporting 61 (58.1%). The TMPs believed that pharmacovigilance is not only ADR reporting 67 (63.8%), ADR reporting will improve the healthcare 87 (82.9%), and ADR reporting is as important as treating patient 78 (74.3%). The TMPs reported updating their knowledge 84 (80.0%), belonging to professiona bodies 80 (76.2%), and willing to implement ADR reporting in their practice 85 (81.0%). The overall mean scores for the knowledge, perception and barriers were 3.57 ± 2.10, 4.99 ± 1.42 and 4.44 ± 1.52, respectively. There was association between knowledge and age, ownership rank and years of experience (p < 0.05), between perception and age (p < 0.05), and between barriers and practice setting (p < 0.05). This study revealed deficiency in knowledge with a positive perception of ADR reporting among TMPs. However, barriers were not significant This suggests the need for advocacy and training of the TMPs on ADRs.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Bandaranayake WM. Quality control, screening, toxicity and regulations of herbal drugs. In: Ahmad I, Aquil F and Owais M Modern Phytomedicine: Turning medicinal plants into drugs. WILEY-VCH Verlag GmbH Co.; 2006. 394 p.
Mukherjee PK. Quality control of herbal drugs: an approach to evaluation of botanicals. (1st ed.).India. New Delhi: Business Horizons; 2002. 113-119 p.
Bodeker G and Ong C-K. WHO global atlas of traditional, complementary and alternative medicine. World Health Organization, 2005.
Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess. 2001; 43(1-10):1-668.
World Health Organisation. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. 2004.
World Health Organisation. WHO traditional medicine strategy: 2014-2023. Geneva Switzerland. 2013.
Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use? BMC Med. 2011; 9: 94.
Bhati N, Khosla P, Gupta S. Assessment of Knowledge, Attitude and Practices (KAP) of Health Professionals Towards Adverse Drug Reactions (ADRs) and Pharmacovigilance in a Tertiary Hospital of North India. GSTF J Adv Med Res. 2018; 1(1): 94-98.
Goyal M, Bansal M, Yadav S, Grover V. Preetkanwal: To assess the Attitude, knowledge and practices of medical professionals about Adverse drug reactions and their reporting in a teaching hospital. Indian J Clin Prac. 2013; 24(3): 281-284.
Khan SA, Goyal C, Tonpay S. A study of knowledge, attitudes, and practice of dental doctors about adverse drug reaction reporting in a teaching hospital in India. Perspec Clin Res. 2015; 6(3):144-149.
Jeetu G and Anusha G. Pharmacovigilance: a worldwide master key for drug safety monitoring. J Young Pharm. 2010; 2(3): 315-320.
Shetti S, Kumar CD, Sriwastava NK, Sharma IP. Pharmacovigilance of herbal medicines: Current state and future directions. Pharmacogn Mag. 2011; 7(25):69-73.
Zhou J, Ouedraogo M, Qu F, Duez P. Potential genotoxicity of traditional chinese medicinal plants and phytochemicals: an overview. Phytother Res. 2013; 27(12): 1745-1755.
Khan TM. Community pharmacists’ knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther Adv Drug Safety. 2013; 4(2): 45-51.
Santosh KC, Tragulpiankit P, Edwards IR, Gorsanan S. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal. Int J Risk SafeMed. 2013; 25(1):1-16.
Gurmesa LT and Dedefo MG. Factors affecting adverse drug reaction reporting of healthcare professionals and their knowledge, attitude, and practice towards ADR reporting in Nekemte Town, West Ethiopia. BioMed Res Int. 2016; 2016: 1-6.
Alsaleh F, Lemay J, Al Dhafeeri R, Alajmi S, Abahussain E, Bayoud T. Adverse drug reaction reporting among physicians working in private and government hospitals in Kuwait. Saudi Pharm J. 2017; 25 (8):1184-1193.
Madu EP and Ineta B-EL. A Study on the Knowledge and Barriers Towards ADRs Reporting among Community Pharmacists in Enugu and Nsukka areas, South-Eastern Nigeria. Pharmacol Toxicol Biomed Rep. 2017; 3(1): 1-6.
O’Callaghan J, Griffin BT, Morris JM, Bermingham M. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland. Bio Drugs. 2018; 32(3): 267-280.
Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey. Drug Safety. 2016; 39(12):1239-1250.
Abdel-Latif MMM and Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al- Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015; 23(2): 154-161.
Santosh KC, Tragulpiankit P, Edwards IR, Gorsanan S. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal. Int J Risk Saf Med. 2013; 25(1): 1-16.
Ohaju-Obodo JO and Iribhogbe OI. Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria. Pharmacoepidemiol Drug Saf. 2010; 19(2): 191-195.
Abubakar US, Abdullahi S, Ayuba V, Kaigama S, Halidu US, Ayuba MK. Medicinal plants used for the management of diabetes mellitus in Zaria, Kaduna state, Nigeria. J Pharm Pharmacogn Res. 2017; 5(2): 156-164.
Adefolaju T. Traditional and orthodox medical systems in Nigeria: The imperative of a synthesis. Am J Health Res. 2014; 2(4):118-124.
Fadare JO, Enwere OO, Afolabi A, Chedi B, Musa A. Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria. Trop J Pharm Res. 2011; 10(3): 235-242.
Gupta P and Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors. J Pharm Sci Res. 2011; 3(2):1064-1069.
Kiran L, Shivashankaramurthy K, Bhooma S, Dinakar K. Adverse drug reaction reporting among clinicians in a teaching hospital in South Karnataka. Scholars J App Med Sci. 2014; 2(1D):399-403.
Panja B, Bhowmick S, Chowrasia V, Bhattacharya S, Chatterjee R, Sen A, Sarkar M, Ram A, Mukherjee P. A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India. Ind J Pharmacol. 2015; 47(1):126-127.
Alshakka M, Bassalim H, Alsakkaf K, Mokhtar M, Alshagga M, Al-Dubai S, Jha N, Abdoraboo A, Shanker PR. Knowledge and perception towards pharmacovigilance among Healthcare professionals in Tertiary care Teaching Hospital in Aden, Yemen. J Pharm Pract Comm Med. 2016; 2(1): 21-28.
Ting K-N, Stratton-Powell DM, Anderson C. Community pharmacists’ views on adverse drug reactions reporting in Malaysia: a pilot study. Pharm World Sci. 2010; 32(3):339- 342.
Krska J. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs). Pharmacoepidemiol Drug Saf. 2013; 22(10): 1130-1133.
Khalili H, Farsaei S, Rezaee H, Dashti-Khavidaki S. Role of clinical pharmacists’ interventions in detection and prevention of medication errors in a medical ward. Int J Clin Pharm. 2011; 33(2):281-284.
Hanafi S, Torkamandi H, Hayatshahi A, Gholami K, Shahmirzadi NA, Javadi MR. An educational intervention to improve nurses' knowledge, attitude, and practice toward reporting of adverse drug reactions. Iranian J Nurs Midwife Res. 2014; 19(1): 101-106.
Xu H and Chen K-j. Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese J Integr Med. 2011; 17(2): 83-84.
Adefolaju T. The dynamics and changing structure of traditional healing system in Nigeria. Int J Health Res. 2011; 4(2):99-106.
Awodele O, Amagon KI, Wannang NN, Aguiyi JC. Traditional medicine policy and regulation in Nigeria: an index of herbal medicine safety. Curr Drug Saf. 2014; 9(1): 16-22.
John LJ, Arifulla M, Cheriathu JJ, Sreedharan J. Reporting of adverse drug reactions: an exploratory study among nurses in a teaching hospital, Ajman, United Arab Emirates. DARU J Pharm Sci. 2012; 20(44):1-6.
Agarwal R, Daher AM, Mohd Ismail N. Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in malaysia. Malays J Med Sci. 2013; 20(2):52-61.
Paveliu MS, Bengea-Luculescu S, Toma M, Paveliu SF. Perception on adverse drug reaction reporting by physicians working in southern romania. Maedica (Buchar). 2013; 8(1):17-25.